Human medicines European public assessment report (EPAR): Olazax Disperzi, olanzapine, Date of authorisation: 10/12/2009, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Zoledronic acid Actavis, zoledronic acid, Date of authorisation: 20/04/2012, Revision: 16, Status: Withdrawn
EMA actively monitoring cruise ship Hantavirus outbreak
Human medicines European public assessment report (EPAR): Zoledronic Acid Hospira, zoledronic acid, Date of authorisation: 19/11/2012, Revision: 19, Status: Withdrawn
EMA business hours over Ascension Day holidays, 14 and 15 May
Article 57 product data
Workshop on Vulnerability Assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 March 2026, 09:30 (CET) to 18 March 2026, 12:30 (CET)
Veterinary medicines European public assessment report (EPAR): Emepax, maropitant, Status: Authorised
PSUSA/00002540/202509
Veterinary medicines European public assessment report (EPAR): AviGate S. Infantis, Salmonella Infantis vaccine (live), Status: Authorised